Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
aged (15) 15
index medicus (14) 14
middle aged (14) 14
female (13) 13
male (13) 13
pain (11) 11
adult (9) 9
care and treatment (9) 9
medicine & public health (9) 9
oncology (9) 9
prevalence (9) 9
aged, 80 and over (8) 8
opioids (8) 8
pharmacology & pharmacy (7) 7
cancer (6) 6
epidemiology (6) 6
internal medicine (6) 6
italy (6) 6
management (6) 6
pain management (6) 6
breakthrough pain (5) 5
cancer pain (5) 5
chronic pain (5) 5
chronic pain - drug therapy (5) 5
herpes zoster (5) 5
pain measurement (5) 5
pharmacology/toxicology (5) 5
quality of life (5) 5
retrospective studies (5) 5
analgesics (4) 4
cardiology (4) 4
diagnosis (4) 4
drug combinations (4) 4
endocrinology (4) 4
health technology assessment (4) 4
herpes zoster - epidemiology (4) 4
herpes zoster - prevention & control (4) 4
italy - epidemiology (4) 4
medicine, research & experimental (4) 4
methods (4) 4
neoplasms - complications (4) 4
oxycodone (4) 4
palliative care (4) 4
postherpetic neuralgia (4) 4
quality-of-life (4) 4
rheumatology (4) 4
safety (4) 4
settore med/41 - anestesiologia (4) 4
treatment outcome (4) 4
analgesics, opioid - therapeutic use (3) 3
breakthrough pain - epidemiology (3) 3
burden (3) 3
cancer therapies (3) 3
cancer-pain (3) 3
combination (3) 3
constipation (3) 3
evidence-based medicine (3) 3
herpes zoster - complications (3) 3
immunization (3) 3
impact (3) 3
incidence (3) 3
naloxone (3) 3
narcotics (3) 3
neuropathic pain (3) 3
older-adults (3) 3
original research (3) 3
oxycodone - administration & dosage (3) 3
oxycodone - adverse effects (3) 3
patients (3) 3
prevention (3) 3
recommendations (3) 3
research (3) 3
risk (3) 3
severity of illness index (3) 3
studies (3) 3
surveys and questionnaires (3) 3
admission (2) 2
adolescent (2) 2
age (2) 2
alleles (2) 2
analgesics - adverse effects (2) 2
analgesics - therapeutic use (2) 2
analgesics, opioid - adverse effects (2) 2
association (2) 2
base sequence (2) 2
biotechnology & applied microbiology (2) 2
breakthrough pain - drug therapy (2) 2
breakthrough pain - therapy (2) 2
care (2) 2
child (2) 2
child, preschool (2) 2
chondroma (2) 2
chondrosarcoma (2) 2
chronic noncancer pain (2) 2
chronic pain - complications (2) 2
chronic pain - etiology (2) 2
classification (2) 2
clinical neurology (2) 2
clinical trials (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
by Loguercio, Carmela and Andreone, Pietro and Brisc, Ciprian and Brisc, Michaela Cristina and Bugianesi, Elisabetta and Chiaramonte, Maria and Cursaro, Carmela and Danila, Mirela and de Sio, Ilario and Floreani, Annarosa and Freni, Maria Antonietta and Grieco, Antonio and Groppo, Marzia and Lazzari, Roberta and Lobello, Salvatore and Lorefice, Elisabetta and Margotti, Marzia and Miele, Luca and Milani, Stefano and Okolicsanyi, Lajos and Palasciano, Giuseppe and Portincasa, Piero and Saltarelli, Patrizia and Smedile, Antonina and Somalvico, Francesco and Spadaro, Aldo and Sporea, Ioan and Sorrentino, Paolo and Vecchione, Raffaela and Tuccillo, Concetta and Blanco, Camillo Del Vecchio and Federico, Alessandro
Free Radical Biology and Medicine, ISSN 0891-5849, 05/2012, Volume 52, Issue 9, pp. 1658 - 1665
The only currently recommended treatment for nonalcoholic fatty liver disease (NAFLD) is lifestyle modification. Preliminary studies of silybin showed... 
Silybin | Hepatoprotectant | Free radicals | Antioxidant | Nonalcoholic fatty liver | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHRONIC HEPATITIS-C | MARIANUM L. GAERTN | DIABETES-MELLITUS | MILK THISTLE | E-PHOSPHOLIPID COMPLEX | INSULIN-RESISTANCE | CLINICAL-TRIALS | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | STEATOHEPATITIS | LONG-TERM TREATMENT | Body Mass Index | Silymarin - therapeutic use | Romania | Humans | Phosphatidylcholines - administration & dosage | Vitamin E - administration & dosage | Vitamin E - therapeutic use | Fatty Liver - drug therapy | Phosphatidylcholines - therapeutic use | Silymarin - administration & dosage | Enzymes | Care and treatment | Liver diseases | Clinical trials | Aspartate | Phospholipids | Transforming growth factors | Vitamins | Antioxidants | Complications and side effects | Fatty liver | Vitamin E | Hepatitis C | Hepatitis C virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
by Liu, Xiangdong and Invernizzi, Pietro and Lu, Yue and Kosoy, Roman and Lu, Yan and Bianchi, Ilaria and Podda, Mauro and Xu, Chun and Xie, Gang and MacCiardi, Fabio and Selmi, Carlo and Lupoli, Sara and Shigeta, Russell and Ransom, Michael and Lleo, Ana and Lee, Annette T and Mason, Andrew L and Myers, Robert P and Peltekian, Kevork M and Ghent, Cameron N and Bernuzzi, Francesca and Zuin, Massimo and Rosina, Floriano and Borghesio, Elisabetta and Floreani, Annarosa and Lazzari, Roberta and Niro, Grazia and Andriulli, Angelo and Muratori, Luigi and Muratori, Paolo and Almasio, Piero L and Andreone, Pietro and Margotti, Marzia and Brunetto, Maurizia and Coco, Barbara and Alvaro, Domenico and Bragazzi, Maria C and Marra, Fabio and Pisano, Alessandro and Rigamonti, Cristina and Colombo, Massimo and Marzioni, Marco and Benedetti, Antonio and Fabris, Luca and Strazzabosco, Mario and Portincasa, Piero and Palmieri, Vincenzo O and Tiribelli, Claudio and Croce, Lory and Bruno, Savino and Rossi, Sonia and Vinci, Maria and Prisco, Cleofe and Mattalia, Alberto and Toniutto, Pierluigi and Picciotto, Antonio and Galli, Andrea and Ferrari, Carlo and Colombo, Silvia and Casella, Giovanni and Morini, Lorenzo and Caporaso, Nicola and Colli, Agostino and Spinzi, Giancarlo and Montanari, Renzo and Gregersen, Peter K and Heathcote, E Jenny and Hirschfield, Gideon M and Siminovitch, Katherine A and Amos, Christopher I and Gershwin, M Eric and Seldin, Michael F
Nature Genetics, ISSN 1061-4036, 08/2010, Volume 42, Issue 8, pp. 658 - 660
A genome-wide association screen for primary biliary cirrhosis risk alleles was performed in an Italian cohort. The results from the Italian cohort replicated... 
SYSTEMIC-LUPUS-ERYTHEMATOSUS | VARIANTS | SPI-B | TRANSCRIPTION | GENETICS & HEREDITY | RISK | ASTHMA | CELL | EXPRESSION | Canada | Interferon Regulatory Factors | European Continental Ancestry Group - genetics | Genome-Wide Association Study | Meta-Analysis as Topic | Humans | Alleles | Liver Cirrhosis, Biliary | Genome | Odds Ratio | Autoimmunity | Chromosome mapping | Autoantibodies | Genomics | Development and progression | Genetic aspects | Biliary cirrhosis | Research | Properties | Methods | Celiac disease | Medical research | Disease | Autoimmune diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different Etiopathogenesis
by Gatti, Antonio and Lazzari, Marzia and Gianfelice, Valentina and Di Paolo, Annarita and Sabato, Elisabetta and Sabato, Alessandro Fabrizio
Pain Medicine, ISSN 1526-2375, 09/2012, Volume 13, Issue 9, pp. 1121 - 1130
Objective.  To assess the efficacy and safety of palmitoylethanolamide (PEA), an endogenous fatty acid amide belonging to the N‐acylethanolamines family, in... 
Immune Cells | Palmitoylethanolamide | Pain Management | Chronic Pain | Immune cells | Chronic pain | Pain management | MAST-CELLS | PROPHYLACTIC EFFICACY | PALMITAMIDE IMPULSIN | NEUROPATHIC PAIN | NEUROTROPHIC FACTORS | MEDICINE, GENERAL & INTERNAL | POSTHERPETIC NEURALGIA | HERPES-ZOSTER | PERIPHERAL NEUROPATHY | SPINAL-CORD-INJURY | QUALITY-OF-LIFE | Chronic Pain - drug therapy | Humans | Middle Aged | Palmitic Acids - therapeutic use | Male | Treatment Outcome | Young Adult | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Aged, 80 and over | Adult | Ethanolamines - therapeutic use | Female | Aged | Chronic Pain - etiology | Endocannabinoids - therapeutic use | Care and treatment | Pain | Analgesics | Fatty acids | Medical research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: A propensity analysis
by Lazzari, Marzia and Greco, Maria Teresa and Marcassa, Claudio and Finocchi, Simona and Caldarulo, Clarissa and Corli, Oscar
Drug Design, Development and Therapy, ISSN 1177-8881, 11/2015, Volume 9, pp. 5863 - 5872
Background: World Health Organization step III opioids are required to relieve moderate-to-severe cancer pain; constipation is one of the most frequent... 
Analgesia | Cancer pain | Naloxone | Propensity analysis | Oxycodone | cancer pain | MODERATE | CHEMISTRY, MEDICINAL | INDUCED CONSTIPATION | SCORE | CHRONIC PAIN | IMPROVES BOWEL FUNCTION | analgesia | VALIDATION | propensity analysis | PROLONGED-RELEASE TABLETS | NEUROPATHIC PAIN | oxycodone | naloxone | PHARMACOLOGY & PHARMACY | CLINICAL IMPORTANCE | OUTCOMES | Constipation - prevention & control | Chronic Pain - diagnosis | Narcotic Antagonists - administration & dosage | Humans | Middle Aged | Male | Laxatives - therapeutic use | Constipation - psychology | Neoplasms - complications | Analgesics, Opioid - adverse effects | Constipation - diagnosis | Rome | Time Factors | Female | Surveys and Questionnaires | Oxycodone - adverse effects | Retrospective Studies | Chronic Pain - etiology | Severity of Illness Index | Chronic Pain - drug therapy | Oxycodone - administration & dosage | Defecation - drug effects | Narcotic Antagonists - adverse effects | Treatment Outcome | Neoplasms - psychology | Chronic Pain - psychology | Constipation - physiopathology | Constipation - chemically induced | Propensity Score | Analgesics, Opioid - administration & dosage | Naloxone - adverse effects | Quality of Life | Aged | Naloxone - administration & dosage | Pain Measurement | Drug Combinations | Evaluation | Cancer patients | Care and treatment | Pain | Patient outcomes | Physiological aspects | Drug therapy, Combination | Methods | Substance abuse treatment | Clinical trials | Cancer therapies | Analgesics | Vomiting | Intestine | Questionnaires | Opioids | Safety | Health surveys | Constipation | Drug dosages | Chronic illnesses | Pain perception | Statistical analysis | Effectiveness | Narcotics | Nausea | Quality of life | Studies | Side effects | Sleep | Palliative care | Comparative analysis | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text One-year follow-up of patients with long-lasting post-herpetic neuralgia
by Pica, Francesca and Gatti, Antonio and Divizia, Marco and Lazzari, Marzia and Ciotti, Marco and Sabato, Alessandro Fabrizio and Volpi, Antonio
BMC Infectious Diseases, ISSN 1471-2334, 11/2014, Volume 14, Issue 1, p. 556
Background: Recent information on epidemiology and management of post-herpetic neuralgia (PHN), a painful complication of zoster, is scarce. Methods: This... 
Post-herpetic neuralgia (PHN) | Herpes zoster (HZ) | Chronic pain | Quality of life | POPULATION | INFECTIOUS DISEASES | ANTIVIRAL THERAPY | GENERAL-PRACTICE | NATURAL-HISTORY | BLOOD MONONUCLEAR-CELLS | NEUROPATHIC PAIN | DNA | VARICELLA-ZOSTER-VIRUS | HERPES-ZOSTER | QUALITY-OF-LIFE | Analgesics - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Male | Risk | Treatment Outcome | Neuralgia, Postherpetic - drug therapy | Neuralgia - drug therapy | Exanthema - chemically induced | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Aged | Analgesics - adverse effects | Complications and side effects | Care and treatment | Neuralgia | Shingles (Disease) | Patients | Standards | Pain | Research | Epidemiology | Studies | Laboratories | Pathogenesis | Pain management | Deoxyribonucleic acid--DNA | Methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance
by Colombo, Michela and Garavelli, Silvia and Mazzola, Mara and Platonova, Natalia and Giannandrea, Domenica and Colella, Raffaella and Apicella, Luana and Lancellotti, Marialuigia and Lesma, Elena and Ancona, Silvia and Palano, Maria Teresa and Barbieri, Marzia and Taiana, Elisa and Lazzari, Elisa and Basile, Andrea and Turrini, Mauro and Pistocchi, Anna and Neri, Antonino and Chiaramonte, Raffaella
Haematologica, ISSN 0390-6078, 10/2019, p. haematol.2019.221077
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-step i drugs in elderly patients with chronic pain at high risk of early opioid discontinuation
by Lazzari, Marzia and Marcassa, Claudio and Natoli, Silvia and Carpenedo, Roberta and Caldarulo, Clarissa and Silvi, Maria B and Dauri, Mario
Clinical Interventions in Aging, ISSN 1176-9092, 05/2016, Volume 11, pp. 641 - 649
Purpose: Chronic pain has a high prevalence in the aging population. Strong opioids also should be considered in older people for the treatment of moderate to... 
Opioid | Naloxone | Elderly | Oxycodone | Chronic pain | chronic pain | INDUCED CONSTIPATION | MANAGEMENT | elderly | opioid | PREVALENCE | COMBINATION | GERIATRICS & GERONTOLOGY | FRACTURE | CHRONIC NONMALIGNANT PAIN | IMPACT | THERAPY | INDUCED BOWEL DYSFUNCTION | oxycodone | naloxone | Severity of Illness Index | Chronic Pain - drug therapy | Oxycodone - administration & dosage | Humans | Male | Constipation - chemically induced | Delayed-Action Preparations - administration & dosage | Analgesics, Opioid - adverse effects | Naloxone - adverse effects | Aged, 80 and over | Quality of Life | Female | Italy | Aged | Oxycodone - adverse effects | Retrospective Studies | Naloxone - administration & dosage | Pain Measurement | Drug Combinations | Usage | Care and treatment | Pain | Analgesics | Opioids | Aged patients | Dosage and administration | Research | Drug therapy | Methods | Substance abuse treatment | Narcotics | Review boards | Cognitive ability | Patients | Cancer therapies | Quality of life | Antidepressants | Older people | Laxatives | Internet | Nonsteroidal anti-inflammatory drugs | Constipation | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Factors influencing the clinical presentation of breakthrough pain in cancer patients
by Mercadante, Sebastiano and Marchetti, Paolo and Cuomo, Arturo and Caraceni, Augusto and Mediati, Rocco Domenico and Vellucci, Renato and Mammucari, Massimo and Natoli, Silvia and Lazzari, Marzia and Dauri, Mario and Adile, Claudio and Airoldi, Mario and Azzarello, Giuseppe and Bandera, Mauro and Blasi, Livio and Cartenì, Giacomo and Chiurazzi, Bruno and Costanzo, Benedetta Veruska Pierpaola and Degiovanni, Daniela and Fusco, Flavio and Guardamagna, Vittorio and Iaffaioli, Vincenzo and Liguori, Simeone and Palermo, Loredana and Mameli, Sergio and Masedu, Francesco and Mattioli, Rodolfo and Mazzei, Teresita and Melotti, Rita Maria and Menardo, Valentino and Miotti, Danilo and Moroso, Stefano and Pascoletti, Gaetano and De Santis, Stefano and Orsetti, Remo and Papa, Alfonso and Ricci, Sergio and Scelzi, Elvira and Sofia, Michele and Tonini, Giuseppe and Valle, Alessandro and Aielli, Federica and IOPS-MS Study Grp and IOPS-MS Study Group and on behalf of the IOPS-MS Study Group
Cancers, ISSN 2072-6694, 06/2018, Volume 10, Issue 6, p. 175
Background: The aim of this study was to identify potential variables influencing the clinical presentation of breakthrough cancer pain (BTP). Methods: Cancer... 
Breakthrough pain | Palliative care | Supportive care | Cancer | ONCOLOGY | supportive care | CLASSIFICATION | cancer | PREVALENCE | breakthrough pain | palliative care | CARE | Variables | Pain | Interference | Opioids | Head and neck cancer | Neuropathy | Diagnosis | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Open questions in the treatment of cancer pain: time for a strong evidence-based approach?
by Natoli, Silvia and Lazzari, Marzia and Dauri, Mario
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 01/2015, Volume 16, Issue 1, pp. 1 - 4
Pain affects patients with cancer at any stage of their disease. Yet, it is not adequately treated in a significant percentage of cases. In 1986, the WHO... 
cancer pain | WHO guidelines | evidence-based approach | opioids | Cancer pain | Evidence-based approach | Opioids | MANAGEMENT | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | RECOMMENDATIONS | PHARMACOLOGY & PHARMACY | PREVALENCE | CHRONIC NONCANCER PAIN | World Health Organization | Pain - drug therapy | Humans | Pain Management | Analgesics, Opioid - therapeutic use | Analgesics, Non-Narcotic - therapeutic use | Neoplasms - physiopathology | Evidence-Based Medicine | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Breakthrough pain in patients with controlled or uncontrolled pain: An observational study
by Gatti, Antonio and Gentili, Marta and Baciarello, Marco and Lazzari, Marzia and Marzi, Rossella and Palombo, Elisa and Sabato, Alessandro F and Fanelli, Guido
Pain Research and Management, ISSN 1203-6765, 11/2014, Volume 19, Issue 6, pp. e168 - e171
Background: Breakthrough pain (BTP) is traditionally defined as a pain exacerbation in patients with chronic controlled pain. However, this definition has... 
Oncological pain | Pain treatment | BTP | CANCER-PAIN | DEFINITION | RECOMMENDATIONS | OPIOIDS | PREVALENCE | ASSOCIATION | CARE | CLINICAL NEUROLOGY | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain
by Dauri, Mario and Lazzari, Marzia and Casali, Manuela and Tufaro, Giuseppe and Sabato, Elisabetta and Sabato, Alessandro Fabrizio
Clinical Drug Investigation, ISSN 1173-2563, 2014, Volume 34, Issue 5, pp. 309 - 316
Background and Objectives Treatment for chronic non-cancer neuropathic pain can be complicated by side effects and drug interactions. Combining opioid... 
CONTROLLED-TRIALS | PROLONGED-RELEASE | MORPHINE | GUIDELINES | PHARMACOLOGICAL MANAGEMENT | PHARMACOLOGY & PHARMACY | CONTROLLED-RELEASE OXYCODONE | GABAPENTIN | COMBINATION | Chronic Pain - drug therapy | Humans | Middle Aged | Pain Management | Drug Tolerance | Male | gamma-Aminobutyric Acid - administration & dosage | Pregabalin | Neuralgia - drug therapy | Young Adult | Hydromorphone - administration & dosage | Drug-Related Side Effects and Adverse Reactions | Aged, 80 and over | Adult | Female | Aged | Hydromorphone - therapeutic use | gamma-Aminobutyric Acid - therapeutic use | gamma-Aminobutyric Acid - analogs & derivatives
Journal Article
Details down arrow
12. Full Text Italian Oncological Pain Survey (IOPS): A Multicentre Italian Study of Breakthrough Pain Performed in Different Settings
by Mercadante, Sebastiano and Lazzari, Marzia and Reale, Carlo and Cuomo, Arturo and Fusco, Flavio and Marchetti, Paolo and Mediati, Rocco D and Chiurazzi, Bruno and Ciuffedra, Libero and Caraceni, Augusto and Iaffaioli, Vincenzo and Luzzani, Massimo and Micheletto, Giuseppe and Papa, Alfonso and Raffaeli, William and Valle, Alessandro and Caruso, Michele and Di Costanzo, Francesco and Pinato, Gianpaolo and Nardi, Filippo and Barni, Sandro and Natoli, Silvia and Mammucari, Massimo and Sabato, Alessandro F and Dauri, Mario and IOPS Study Group
The Clinical Journal of Pain, ISSN 0749-8047, 03/2015, Volume 31, Issue 3, pp. 214 - 221
OBJECTIVE:A survey of breakthrough pain (BTP) was performed in five palliative care units (PCU), seven oncology departments (ONC), and nine pain clinics (OPC).... 
Breakthrough pain | Palliative care | Cancer pain | Rapid-onset opioids | Epidemiology | cancer pain | HOSPICE | MANAGEMENT | PREVALENCE | breakthrough pain | CHRONIC CANCER PAIN | rapid-onset opioids | palliative care | CLINICAL NEUROLOGY | epidemiology | ADMISSION | ANESTHESIOLOGY | EPISODIC PAIN | Predictive Value of Tests | Humans | Middle Aged | Pain Clinics - statistics & numerical data | Breakthrough Pain - epidemiology | Male | Neoplasms - complications | Health Surveys | Time Factors | Breakthrough Pain - therapy | Quality of Life | Female | Italy | Aged | Palliative Care - statistics & numerical data | Pain Measurement | Breakthrough Pain - etiology | Neoplasms - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Breakthrough pain in patients with controlled or uncontrolled pain: An observational study/L'accès douloureux paroxystique chez des patients souffrant de douleur contrôlée ou incontrôlée : une étude d'observation
by Antonio Gatti and Marta Gentili and Marco Baciarello and Marzia Lazzari and Rossella Marzi and Elisa Palombo and Alessandro F Sabato and Guido Fanelli
Pain Research & Management : The Journal of the Canadian Pain Society, ISSN 1203-6765, 11/2014, Volume 19, Issue 6, p. E168
  Breakthrough pain (BTP) is traditionally defined as a pain exacerbation in patients with chronic controlled pain. However, this definition has recently been... 
Studies | Pain management | Patients | Cancer therapies | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Retrospective Evaluation of a Fixed-Dose Combination of Oxycodone and Acetaminophen to Manage Moderate Pain: The Lower the Better
by Natoli, Silvia and Lazzari, Marzia and Carpenedo, Roberta and Palombo, Elisa and Silvi, Maria Beatrice and Mammucari, Massimo and Dauri, Mario
Advances in Therapy, ISSN 0741-238X, 6/2016, Volume 33, Issue 6, pp. 1025 - 1032
Oxycodone is one of the most commonly used opioid analgesics in the clinical management of pain. The present retrospective analysis aimed to determine the dose... 
Oxycodone | Rheumatology | Opioid | Internal Medicine | Oncology | Retrospective | Numeric pain rating scale | Pain | Medicine & Public Health | Acetaminophen | Cardiology | Pharmacology/Toxicology | Endocrinology | MEDICINE, RESEARCH & EXPERIMENTAL | GUIDELINES | OPIOIDS | PHARMACODYNAMICS | CANCER | THERAPY | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | ANALGESICS | CHRONIC NONCANCER PAIN | OXYCODONE/PARACETAMOL | Acetaminophen - adverse effects | Substance-Related Disorders - etiology | Pain - epidemiology | Oxycodone - administration & dosage | Humans | Middle Aged | Acetaminophen - administration & dosage | Pain Management - methods | Analgesics - administration & dosage | Male | Dose-Response Relationship, Drug | Pain Measurement - methods | Substance-Related Disorders - prevention & control | Pain - drug therapy | Female | Italy - epidemiology | Aged | Oxycodone - adverse effects | Retrospective Studies | Drug Monitoring | Drug Combinations | Analgesics - adverse effects | Pain - diagnosis | Evaluation | Care and treatment | Analysis | Central nervous system depressants | Dosage and administration | Drug therapy, Combination
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text CoCoNet: Towards coast to coast networks of marine protected areas (From the shore to the high and deep sea), coupled with sea-based wind energy potential
by Boero, Ferdinando and Foglini, Federica and Fraschetti, Simona and Goriup, Paul and Macpherson, Enrique and Planes, Serge and Soukissian, Takvor and Adiloglu, Baris and Cristens, Gween and Delahaye, Catherine and Gregory, Ignace and Jacques, Sophie and Velkova, Stanislava and Kontogianni, Areti and Tourkolias, Christos and Kollaras, Aggelos and Damigos, Dimitris and Skourtos, Michalis and Bianco, Luisella and Cesarini, Claudia and Aliani, Stefano and Angeletti, Lorenzo and Barbieri, Laura and Beroldo, Raffaella and Falcieri, Francesco and Grande, Valentina and Griffa, Annalisa and Langone, Leonardo and Lazzari, Paolo and Lobato, Tomas and Miserocchi, Stefano and Palamà, Daniela and Sclavo, Mauro and Solidoro, Cosimo and Suaria, Giuseppe and Taviani, Marco and Toncini, Annamaria and Trincardi, Fabio and Vichi, Marcello and Chassanite, Aurore and Claudet, Joachim and Feral, François and Marill, Laurence and Villa, Elisa and Taquet, Coralie and Boissin, Emilie and Mangialajo, Luisa and Bottin, Lorraine and Paravicini, Valeriano and Baksay, Sandra and Neglia, Valentina and Legoff, Marion and Dinoi, Alessia and Sahyoun, Rita and Bitetto, Isabella and Lembo, Giuseppe and Spedicato, Maria Teresa and Aglieri, Giorgio and Albano, Gabriele and Albano, Orazio and Arena, Giuseppe and Asnaghi, Valentina and Bavestrello, Giorgio and Belmonte, Genuario and Cecchi, Lisandro Benedetti and Bevilacqua, Stanislao and Bo, Marzia and Boscari, Elisa and Bulleri, Fabio and Calculli, Crescenza and Capezzuto, Francesca and Capone, Antonio and Carlucci, Roberto and Carluccio, Angela and Casagrandi, Renato and Vietti, Riccardo Cattaneo and Chiantore, Mariachiara and Chimienti, Giovanni and Ciardo, Lucia and Congiu, Leonardo and Corselli, Cesare and Cutrona, Annibale and D'Onghia, Gianfranco and Bello, Martina Dal and Mura, Ilaria Dalle and De Leo, Francesco and De Leo, Giulio and De Vito, Doris and Di Bella, Marco and Di Camillo, Cristina Gioia and Di Mauro, Maria and Fai, Sergio and Farella, Giulio and Forin, Niccolò and Gatto, Marino and Ghermandi, Andrea and Giangrande, Elisa and Granata, Antonia and Gravili, Cinzia and Guarnieri, Giuseppe and ...
SCIRES-IT, 2016, Volume 6, pp. 1 - 95
Offshore Wind Farms | Wind energy | Connectivity | Economic valuation | Ecosystem functioning | Biodiversity | Marine Spatial Planning | Networks of Marine Protected Areas | Black Sea | Mediterranean Sea
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience
by Gabutti, Giovanni and Bonanni, Paolo and Conversano, Michele and Fanelli, Guido and Franco, Elisabetta and Franco, Elisabetta and Greco, Donato and Icardi, Giancarlo and Icardi, Giancarlo and Lazzari, Marzia and Rossi, Alessandro and Scotti, Silvestro and Volpi, Antonio
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 02/2017, Volume 13, Issue 2, pp. 391 - 398
Herpes zoster (HZ) is an acute viral illness characterized by a vesicular rash with unilateral distribution, which can also result in severe complications such... 
real world experiences | Herpes zoster | immunization | prevention | clinical evidence | RISK-FACTORS | AGED 50 YEARS | SAFETY | OLDER-ADULTS | IMMUNOLOGY | VARICELLA VACCINATION | IMPACT | POSTHERPETIC NEURALGIA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | QUALITY-OF-LIFE | BURDEN | EPIDEMIOLOGY | Herpes Zoster - prevention & control | Humans | Middle Aged | Herpes Zoster - complications | Europe - epidemiology | Herpes Zoster Vaccine - administration & dosage | Incidence | Nervous System Diseases - epidemiology | Nervous System Diseases - prevention & control | Vaccines, Attenuated - immunology | Vaccines, Attenuated - administration & dosage | Aged, 80 and over | Nervous System Diseases - etiology | Aged | Herpes Zoster - epidemiology | Herpes Zoster Vaccine - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights